Key Metrics
CiteScore 

0.9
SNIP 

0.32
Recommended pre-submission checks
Powered by 

Topics Covered on Current Drug Therapy
Current Drug Therapy Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Semi-annual |
| General Details | |
| Language | English |
| Frequency | Semi-annual |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Drug Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Drug Therapy
Challenges and Innovations in Disintegrating Tablets for Multi-Unit Pellet Systems
- 30 Apr 2026
- Current Drug Therapy
Guipi Tang Regulates Metabolic Reprogramming at the Maternal-Fetal Interface in a Mouse Model of Unexplained Recurrent Spontaneous Abortion
- 29 Apr 2026
- Current Drug Therapy
Unveiling Synergy: A Tandem RP-HPLC Method for Exemestane and Bosutinib Quantification
- 29 Apr 2026
- Current Drug Therapy
Rehmannioside D Inhibits Osteoclast Differentiation and Osteolysis in vitro Through Downregulating the Akt/Runx2 Axis in Mouse Bone Marrow- derived Macrophages
- 8 Apr 2026
- Current Drug Therapy
<i>In Silico</i> Evaluation of Quinazoline-Based EGFR Inhibitors with Anticancer Activity
- 7 Apr 2026
- Current Drug Therapy
Apixaban Pharmacotherapy Management: A Current and Updated Review
- 27 Mar 2026
- Current Drug Therapy
Challenges and Innovations in Disintegrating Tablets for Multi-Unit Pellet Systems
- 30 Apr 2026
- Current Drug Therapy
Guipi Tang Regulates Metabolic Reprogramming at the Maternal-Fetal Interface in a Mouse Model of Unexplained Recurrent Spontaneous Abortion
- 29 Apr 2026
- Current Drug Therapy
Unveiling Synergy: A Tandem RP-HPLC Method for Exemestane and Bosutinib Quantification
- 29 Apr 2026
- Current Drug Therapy
Rehmannioside D Inhibits Osteoclast Differentiation and Osteolysis in vitro Through Downregulating the Akt/Runx2 Axis in Mouse Bone Marrow- derived Macrophages
- 8 Apr 2026
- Current Drug Therapy
<i>In Silico</i> Evaluation of Quinazoline-Based EGFR Inhibitors with Anticancer Activity
- 7 Apr 2026
- Current Drug Therapy
Apixaban Pharmacotherapy Management: A Current and Updated Review
- 27 Mar 2026
- Current Drug Therapy